COMPARATIVE METABOLISM OF FLUNARIZINE IN RATS, DOGS AND MAN - AN INVITRO STUDY WITH SUBCELLULAR LIVER FRACTIONS AND ISOLATED HEPATOCYTES

被引:29
作者
LAVRIJSEN, K [1 ]
VANHOUDT, J [1 ]
VANDYCK, D [1 ]
HENDRICKX, J [1 ]
BOCKX, M [1 ]
HURKMANS, R [1 ]
MEULDERMANS, W [1 ]
LEJEUNE, L [1 ]
LAUWERS, W [1 ]
HEYKANTS, J [1 ]
机构
[1] JANSSEN RES FDN,DEPT ANALYT RES,B-2340 BEERSE,BELGIUM
关键词
D O I
10.3109/00498259209053143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The biotransformation of H-3-flunarizine ((E)-l-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride, FLUN) was studied in subcellular liver fractions (microsomes and 12 000 g fraction) and in suspensions or primary cell cultures of isolated hepatocytes of rats, dogs and man. The major in vitro metabolites were characterized by h.p.l.c. co-chromatography and/or by mass spectrometric analysis. 2. The kinetics of FLUN metabolism was studied in microsomes of dog and man. The metabolism followed linear Michaelis-Menten kinetics over the concentration range 0-1-20-mu-m FLUN. 3. A striking sex difference was observed for the in vitro metabolism of FLUN in rat. In male rats, oxidative N-dealkylation at one of the piperazine nitrogens, resulting in bis (4-fluorophenyl) methanol, was a major metabolic pathway, whereas aromatic hydroxylation at the phenyl of the cinnamyl moiety, resulting in hydroxy-FLUN, was a major metabolic pathway in female rats. In incubates with hepatocytes, these two metabolites were converted to the corresponding glucuronides. 4. In human subcellular fractions, aromatic hydroxylation to hydroxy-FLUN was the major metabolic pathway. In primary cell cultures of human hepatocytes, oxidative N-dealkylation at the 1- and 4-piperazine nitrogen and glucuronidation of bis(4-fluorophenyl)methanol were observed. The in vitro metabolism of FLUN in humans, resembled more that in female rats and in dogs than that in male rats. 5. The present in vitro results are compared with data of previous in vivo studies in rats and dogs. The use of subcellular fractions and/or isolated hepatocytes for the study of species differences in the biotransformation of xenobiotics is discussed.
引用
收藏
页码:815 / 836
页数:22
相关论文
共 42 条
  • [1] Amri H, 1986, XENOBIOTICA, V16, P351
  • [2] BEAUNE PH, 1986, DRUG METAB DISPOS, V14, P437
  • [3] MOLYBDENUM HYDROXYLASES AS DRUG-METABOLIZING-ENZYMES
    BEEDHAM, C
    [J]. DRUG METABOLISM REVIEWS, 1985, 16 (1-2) : 119 - 156
  • [4] HUMAN CYTOCHROMES-P-450
    BOOBIS, AR
    DAVIES, DS
    [J]. XENOBIOTICA, 1984, 14 (1-2) : 151 - 185
  • [5] Borchardt RT, 1980, ENZYMATIC BASIS DETO, V2, P43
  • [6] BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
  • [7] Caldwell J., 1982, METABOLIC BASIS DETO, P291
  • [8] CHENERY RJ, 1987, DRUG METAB DISPOS, V15, P312
  • [9] CHARACTERIZATION OF MIDAZOLAM METABOLISM USING HUMAN HEPATIC-MICROSOMAL FRACTIONS AND HEPATOCYTES IN SUSPENSION OBTAINED BY PERFUSING WHOLE HUMAN LIVERS
    FABRE, G
    RAHMANI, R
    PLACIDI, M
    COMBALBERT, J
    COVO, J
    CANO, JP
    COULANGE, C
    DUCROS, M
    RAMPAL, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (22) : 4389 - 4397
  • [10] HUMAN HEPATOCYTES AS A KEY INVITRO MODEL TO IMPROVE PRECLINICAL DRUG DEVELOPMENT
    FABRE, G
    COMBALBERT, J
    BERGER, Y
    CANO, JP
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 165 - 171